Ehsan Malek, MD¹, Yihong Deng, MS^2*, Mark Eckman, MD^3*, Jeffrey Weldge, PhD^4* and James J. Driscoll, MD, PhD^5,6*

¹Division of Hematology and Oncology, Case Western Reserve University, Cleveland, OH
²University of Cincinnati, Cincinnati, OH
³Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH
⁴Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH
⁵Division of Hematology and Oncology, University of Cincinnati, Cincinnati, OH
⁶The Vontz Center for Molecular Studies, University of Cincinnati, Cincinnati, OH

Christopher Lemieux, MD, Imran Ahmad, MD, Nadia M. Bambace, MD, Lea Bernard, MD, Sandra Cohen, MD, Jean-Sebastien Delisle, MD, PhD, Thomas Kiss, MD, Jean Roy, MD, PhD and Silvy Lachance, MD

Division of Hematology and Medical Oncology, Stem Cell Transplant Program, Department of Medicine, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada

John Sweetenham¹, Jan Walewski, MD PhD Prof², Auayporn P. Nademanee, MD³, Tamas Masszi⁴, Edward Agura⁵, Jerzy Holowiecki⁶, Muneer H. Abidi, MD⁷, Andy I Chen, MD, PhD⁸, Patrick Stiff⁹, Simonetta Viviani, MD^10*, Angelo Michele Carella¹¹, Dzhelil Osmanov^12*, Veronika Bachanova, MD¹³, Anna Sureda, MD, PhD^14*, Dirk Huebner¹⁵, Emily K Larsen^16*, Naomi N Hunder^16* and Craig H Moskowitz, MD¹⁷

¹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
³Department of Hematology and HCT, City of Hope, Duarte, CA
⁴Szent Istvan & Szent Laszlo Corporate Hospital Hematology & Stem Cell Dept., Budapest, Hungary
⁵Baylor University Medical Center, Dallas, TX
⁶Department of Bone Marrow Transplantation & Oncohematology, Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland
⁷Karmanos Cancer Institute, Detroit, MI
⁸Oregon Health & Science University, Portland, OR
⁹Loyola University Medical Center, Maywood, IL
¹⁰Istituto Nazionale dei Tumori, Milan, Italy
¹¹IRCCS Azienda Ospedaliera Universitaria San Martino-Ist, Genova, Italy
¹²Blokhin Cancer Research Center under the Russian Academy of Medical Sciences, Moscow, Russia
¹³University of Minnesota Medical Center, Minneapolis, MN
¹⁴Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
¹⁵Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited, Cambridge, MA
¹⁶Seattle Genetics, Inc., Bothell, WA
¹⁷Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY

Pallawi Torka, MD¹, Paul K. Wallace, MS, PhD^2*, Yali Zhang^1*, George L. Chen, MD^1*, Sophia R. Balderman, MD¹, Bruno Paiva, PhD^3*, Christine M. Ho, MD¹, Maureen Ross, MD¹, Francisco J. Hernandez-Ilizaliturri, MD⁴, Philip L. McCarthy, MD¹ and Theresa Hahn, PhD¹

¹Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
²Department of Pathology, Roswell Park Cancer Inst., Buffalo, NY
³Clínica Universidad de Navarra, Pamplona, Spain
⁴Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, NY

Noa Biran, MD¹, Susanna Jacobus^2*, David S Siegel, MD, PhD³, Natalie Scott Callander, MD⁴, Rafael Fonseca, MD⁵, David H. Vesole, MD⁶, Michael E. Williams, M.D.⁷, Rafat Abonour, MD⁸, Michael S Katz, BS, MBA^9*, S. Vincent Rajkumar¹⁰ and Philip R. Greipp, MD^11*

¹John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA
³Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
⁴University of Wisconsin Carbone Cancer Center, Madison, WI
⁵Mayo Clinic, Scottsdale, AZ
⁶Hackensack University Medical Center, John Theurer Cancer Center at Hackensack UMC, Hackensack, NJ
⁷University of Virginia, Charlottesville, VA
⁸Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN
⁹International Myeloma Foundation, Los Angeles, CA
¹⁰Division of Hematology, Mayo Clinic, Rochester, MN
¹¹Mayo Clinic, Rochester, MN

Phyllis McKiernan, APN, MSN, OCN^1*, David S Siegel, MD, PhD², David H. Vesole, MD¹, Themba Nyirenda, PhD^3*, Scott D. Rowley, MD, FACP¹, Alan P Skarbnik, MD³, Ann Ferolin-Ocot, RN, BSN, OCN^1*, Daniel Kim^1*, Neil Shah, MD^4* and Michele L. Donato, MD¹

¹John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
³Hackensack University Medical Center, Hackensack, NJ
⁴Mountainside, Hackensack University Medical Center, Montclair, NJ

Sara Farshchi-Zarabi, MD^1,2*, Gurdeep Parmar, MD^2*, Esther Masih-Khan, PhD^2*, Sophia Farooki, MD, FRCPC², Christine Chen, MD, FRCPC^2,3, Vishal Kukreti, MD, FRCPC^2,3, Anca Prica, MD, FRCPC^2,3*, Rodger Tiedemann, MBChB, FRCPC, PhD^2,3, Suzanne Trudel, MD^3,4 and Donna Reece^2,3

¹Department of Medicine, University of Toronto, Toronto, ON, Canada
²Princess Margaret Cancer Centre, Toronto, ON, Canada
³Department of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada
⁴Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Yi L. Hwa, NP^*, Shaji K. Kumar, MD, Martha Q. Lacy, MD, Morie A. Gertz, MD, Francis Buadi, MD, S. Vincent Rajkumar, Ronald S. Go, MD, Nelson Leung, MD, Prashant Kapoor, MD, David Dingli, MD, PhD, Stephen J. Russell, MD, PhD, John A. Lust, MD, PhD, Suzanne R. Hayman, MD, Taxiarchis Kourelis, MD and Angela Dispenzieri, MD

Division of Hematology, Mayo Clinic, Rochester, MN

Heather Landau, MD^1,2, Nicole Montanez, BS^3*, Alexandra Cowan, MS^3*, Hoover Elizabeth, BS^3*, Carlos Flombaum, MD^4*, Jennifer Liu, MD^3*, Mat Maurer, MD^5*, Nikoletta Lendvai, MD, PhD^6,7, Ola Landgren, MD, PhD⁷, Sergio A. Giralt, MD^8,9 and Hani Hassoun, MD^1,7

¹Weill Cornell Medical College, New York, NY
²Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
³Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Medicine, Memorial Sloan Ketttering Cancer Center, New York, NY
⁵Department of Medicine, New York Presbyterian Columbia medical Center, New York, NY
⁶Department of Medicine, Weill Cornell Medical College, New York, NY
⁷Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Weill Cornell Medical College, Cornell University, New York, NY
⁹Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

Amrita Y. Krishnan, MD¹, Joycelynne Palmer, PhD^2*, Auayporn P. Nademanee, MD³, Robert Chen¹, Leslie L. Popplewell, MD⁴, Nicole Tsai, MS^5*, James F. Sanchez, PhD^6*, Jennifer Simpson^7*, Ricardo Spielberger, MD⁸, Dave Yamauchi, MD^9* and Stephen J. Forman, MD¹⁰

¹City of Hope National Medical Center, Duarte, CA
²Department of Information Sciences, City of Hope, Duarte, CA
³Department of Hematology and HCT, City of Hope, Duarte, CA
⁴City of Hope, Duarte, CA
⁵Department of Information Sciences, City of Hope Cancer Center, Duarte, CA
⁶Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte
⁷City of Hope, Duarte
⁸Hem/HCT, Kaiser Permanente, Los Angeles, CA
⁹Dept of Radiology, City of Hope Cancer Center, Duarte, CA
¹⁰Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Sam H Ahmedzai, MBChB BSc FRCP^1*, John A Snowden, MD, FRCP, FRCPath^1,2, Angela Cox, BA MA PhD^1*, David A Cairns^3*, Cathy D Williams^4*, Anna Hockaday^5*, Jamie Cavenagh⁶, Christopher Parrish, MD^7*, Kwee L Yong, MBChB, PhD^8*, Jim Cavet, FRCPath^9*, Hannah Hunter¹⁰, Jennifer Bird^11*, John Ashcroft, MD, MBBChir, PhD, MRCP, MA, FRCPath¹², Julia Brown, PhD^13*, Curly Morris, MD¹⁴ and Gordon Cook, MD, PhD¹⁵

¹Department of Oncology, University of Sheffield, Sheffield, United Kingdom
²Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
³Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁴Centre for Clinical Haematology, Nottingham University Hospitals, Nottingham, United Kingdom
⁵Clinical Trials Research Unit, Univeristy of Leeds, Leeds, United Kingdom
⁶Dept. of Hematology, St. Bartholomew's Hospital, London, United Kingdom
⁷St James's Institute of Oncology, Leeds, United Kingdom
⁸Department of Haematology, UCL Cancer Institute, London, United Kingdom
⁹The Christie NHS Foundation Trust, Manchester, United Kingdom
¹⁰Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
¹¹University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
¹²Dept. of Haematology, Pinderfields Hospital, Wakefield, United Kingdom
¹³Univeristy of Leeds, Clincial Trials Research Unit, Leeds, United Kingdom
¹⁴Centre for Cancer Research & Cell Biology, Queen's University of Belfast, Belfast, United Kingdom
¹⁵University of Leeds, Leeds, United Kingdom

Frits van Rhee, MD, PhD¹, Alan Mitchell^2*, Maurizio Zangari, MD¹, Jeffery Sawyer^3*, Sarah Waheed, MD^1*, Rashid Z Khan, MD^1*, Christoph Heuck, MD¹, Sharmilan Thanendrarajan, MD¹, Carolina Schinke, MD^1*, Yogesh Jethava, MD^1*, Xenofon Papanikolaou, MD^1*, Monica Grazziutti^1*, Nathan Petty, MS^1*, Douglas Steward^1*, Susan Panozzo^1*, Clyde Bailey^1*, Antje Hoering^2*, John Crowley, PhD², Faith E Davies, MD¹, Bart Barlogie, MD, PhD¹ and Gareth J Morgan, MD PhD¹

¹Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR
²Cancer Research and Biostatistics, Seattle, WA
³Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR

Sharmilan Thanendrarajan, MD, Caleb K. Stein, MS^*, Faith E Davies, MD, Frits van Rhee, MD, PhD, Maurizio Zangari, MD, Christoph Heuck, MD, Carolina Schinke, MD^*, Sarah Waheed, MD^*, Yogesh Jethava, MB, MRCP, MD, FRCPath, Niels Weinhold, PhD^*, Aasiya Matin^*, Pankaj Mathur^*, Meera Mohan^*, Muthukumar Radhakrishnan^*, Bart Barlogie, MD, PhD and Gareth J Morgan, MD PhD

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Clinton Yam, MBBS¹, Daniel J. Landsburg, MD¹, Xinyi Lin, PhD^2*, Anthony Mato, MD^1*, Jakub Svoboda, MD¹, Alison Loren, MD, MS¹, Noelle Frey, MD¹, Edward A. Stadtmauer, MD¹, David Porter, MD¹, Stephen J. Schuster, MD¹ and Sunita Dwivedy Nasta, MD¹

¹Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
²Singapore Institute for Clinical Sciences, Singapore, Singapore

May Anne Cheong, MBBS, MRCP^1*, Gee Chuan Wong, MBBS, MRCP, FRCP², William YK Hwang, MBBS, MRCP, FRCP², Ho YL Aloysius, MBBS, MRCP, FRCPath^2*, Yeh Ching Linn, MBBS, MRCP^2*, Yeow-Tee YT Goh, MD², Yvonne Loh, MBBS, MRCP³, Sathish Kumar, MBBS, MRCP, FRCPath^2*, Colin Phipps, MBBS, MRCP, FRCPath^2* and Zhentang Lao, MBBS, MRCP^2*

¹Singapore General Hospital, Singapore, Singapore
²Department of Haematology, Singapore General Hospital, Singapore, Singapore
³Raffles Medical Group, Singapore, Singapore

Scott R. Solomon, MD¹, Sanacore Melissa^1*, Xu Zhang^2*, Katelin Connor^1*, Melhem Solh, MD¹, Asad Bashey, MD, PhD¹, Lawrence E. Morris, MD¹ and H. Kent Holland, MD¹

¹The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
²Department of Mathematics and Statistics, Georgia State University, Atlanta, GA

Sai Ravi Pingali, MD¹, Rima Saliba^1*, Paolo Anderlini, MD¹, Chitra M. Hosing, MD¹, Issa F. Khouri, MD¹, Amin M. Alousi, M.D.¹, Partow Kebriaei, MD¹, Yago Nieto, MD, PhD¹, Muzaffar H. Qazilbash, MD¹, Michelle A. Fanale², Elizabeth J. Shpall, MD¹, Richard E. Champlin, MD¹ and Uday R. Popat, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Elias Karl Mai, MD^1*, Christina Kunz, PhD^2*, Uta Bertsch, MD^3*, Hans-Juergen Salwender, MD^4*, Michael Pfreundschuh, MD⁵, Ulrich Duehrsen, MD⁶, Peter Brossart, MD^7*, Norma Peter, MD^8*, Kai Neben, MD^9*, Thomas Hielscher^2*, Jens Hillengass, MD³, Hans Martin, MD^10*, Hans Walter Lindemann, MD^11*, Christof Scheid¹², Katja C. Weisel^13*, Igor W. Blau, MD^14* and Hartmut Goldschmidt, MD^1,15

¹Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany
²Divison of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
³Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁴Asklepios Klinik Altona, Hamburg, Germany
⁵Department of Hematology and Oncology, University Clinic of Saarland, Homburg, Germany, Homburg/Saar, Germany
⁶University Hospital Essen, Essen, Germany
⁷University Hospital Bonn, Bonn, Germany
⁸Internal Medicine, Carl-Thiem-Clinic Cottbus, Cottbus, Germany
⁹Department of Hematology and Oncology, Klinikum Baden Baden, Baden Baden, Germany
¹⁰Department of Hematology/Oncology, Goethe-University of Frankfurt, Frankfurt a. M., Germany
¹¹Klinik für Hämatologie / Onkologie, Kath. Krankenhaus Hagen gem. GmbH - St.-Marien-Hospital, Hagen, Germany
¹²University of Cologne, Cologne, Germany
¹³Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany
¹⁴Internal Medicine, Charité University Medicine Berlin, Berlin, Germany
¹⁵National Center for Tumor Diseases (NCT) Heidelberg, University Hospital Heidelberg, Heidelberg, Germany

Dana Rosenberg, MD^1*, Erel Joffe, MD, MSc^1,2*, Uri Rozovski, MD^1,3, Chava Perry, MD/Ph.D.^3*, Ilya Kirgner, MD^4,5*, Svetlana Trestman, MD^3*, Odelia Gur^3*, Freddy Aviv, MD^3*, Nadav Sarid, MD^3*, Albert Kolomansky, MD^3*, Lily Gepstein^3*, Yair Herishanu, MD^3,5 and Elizabeth Naparstek, MD^1,3

¹Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
²Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
³Department of Hematology and Bone Marrow Transplantation, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁴Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Victor H Jimenez-Zepeda, MD¹, Peter Duggan, MD², Paola Neri, MD, PhD³, Ahsan Chaudhry, MD^4*, Marcia Culham, RN, BSN, NP^5*, Joanne Luider^6*, Fariborz Rashid-Kolvear, PhD^7* and Nizar J Bahlis, MD³

¹University of Calgary, Division of Hematology, Calgary, AB, Canada
²Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
³University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada
⁴Tom Baker Cancer Center, Calgary, AB, Canada
⁵DMOH, Tom Baker Cancer Center, Calgary, AB, Canada
⁶Alberta Health Services, Calgary, AB, Canada
⁷Calgary Lab Services, Calgary, AB, Canada

Ombretta Annibali, MD, PHD^1*, Elisabetta Riva^2*, Livia Piccioni^3*, Francesca Chiodi, MD^4*, Valeria Tomarchio^5*, Daniele Armiento^6*, Erika Circhetta^6*, Alessandra Scardocci^6*, Silvia Ferraro^6*, Maria Cristina Tirindelli, MD^1* and Giuseppe Avvisati, MD, PhD⁷

¹Hematology, University Campus Bio Medico, Rome, Italy
²UOS of Virology, University campus Bio Medico, Rome, Italy
³UOC Virology, University campus Bio Medico, Rome, Italy
⁴Hematology Unit, Policlinico Universitario Campus Biomedico, Roma, Italy
⁵UOC Hematology, University campus Bio Medico, Rome, Italy
⁶UOC Hematology, Policlinico Universitario Campus Bio Medico, Rome, Italy
⁷Hematology, Campus Biomedico University, Rome, Italy

Jonathan E. Brammer, MD¹, Michelle Poon^2*, Liang Piu Koh^3*, Paolo F. Caimi, MD⁴, Marcos De Lima, MD⁵, Celina Ledesma^1*, William Dibb, BA^6*, Issa F. Khouri¹, Yasuhiro Oki, MD⁷, Michelle A. Fanale⁷, Richard E. Champlin, MD¹, Richard T. Maziarz, MD⁸ and Chitra M. Hosing, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²National University Hospital, Singapore, TX, Singapore
³Department of Hematology-Oncology, Singapore
⁴Medicine - Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH
⁵Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland
⁶Center for Hematologic Malignancies, Oregon Health and science university, Portland, OR
⁷Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health & Science University, Portland, OR

Issa F. Khouri¹, Dawen Sui^2*, Francesco Turturro, MD³, William D Erwin^4*, Roland L Bassett Jr.^5*, Martin Korbling⁶, Rosamar Valverde^7*, Sairah Ahmed^7*, Amin M. Alousi, MD¹, Paolo Anderlini⁷, Qaiser Bashir, MD¹, Stefan O. Ciurea, MD¹, Betul Oran, MD¹, Amanda Olson^8*, Uday R. Popat, MD¹, Krina K Patel¹, Muzaffar H. Qazilbash, MD¹, Michelle A. Fanale⁹, Luis E. Fayad, MD³, Loretta Nastoupil, MD¹⁰, Jason R Westin, MD³, Alison M Gulbis^11*, L. Jeffrey Medeiros¹², Ken H. Young¹² and Aaron Jessop^13*

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1411, Houston
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1352, Houston
⁵Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 423, Houston
⁷Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 423, Houston
⁸Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Nuclear Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1483, Houston

Attaya Suvannasankha, MD¹, Sherif Farag, MD, PhD², Rebecca Silbermann, MD³, Mary Cangany, RN^2*, Anita Rush-Taylor, RN^2*, Robin O'Bryant, RN^2*, Lisa Wood, RN^4*, Jean Pearson^4*, Sarah Singleton^4*, Andrea Bradley^4*, Sandra Althouse^5*, Susan Perkins, PhD^6*, Deb Estes, RN^4* and Rafat Abonour, MD⁴

¹Indiana University School of Medicine and Richard L. RoudeBush VA Medical Center, Indianapolis, IN
²Medicine/Hematology-Oncology, Indiana University School of Medicine, Indianapolis, IN
³Medicine/Hematology-Oncology, Indiana University, Indianapolis, IN
⁴Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN
⁵Biostatistics, Indiana University Simon Cancer Center, Indianapolis, IN
⁶Biostatistics, Indiana Univeristy Simon Cancer Center, Indianapolis, IN

Koji Sasaki, MD¹, Nina Shah, MD¹, Qaiser Bashir, MD¹, Chitra M. Hosing, MD¹, Uday R. Popat, MD¹, Yago Nieto, MD, PhD¹, Simrit Parmar, MD¹, Jatin J. Shah, MD², Donna Weber, MD², Daniel Weissinger^1*, Sheeba K. Thomas, MD², Robert Z. Orlowski, MD, PhD², Richard E. Champlin, MD¹ and Muzaffar H. Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Shekeab Jauhari, M.D.^1*, John Plastaras, M.D., Ph.D.^2*, John Lukens, M.D.^2*, Amit Maity, M.D., Ph.D.^2*, Stephen J. Schuster, MD³ and Sunita Dwivedy Nasta, MD⁴

¹University of Pennsylvania, Philadelphia, PA
²Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA
³Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
⁴Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA

Amanda F. Cashen, MD¹, Kendall Gosch, BA^2*, Theresa Fletcher, MS^2*, Connie Ceriotti, RN, BSN^2*, Armin Ghobadi, MD^3*, Ravi Vij, MD², Keith Stockerl-Goldstein, MD⁴, John F Dipersio, MD, PhD⁵ and Camille N Abboud, MD²

¹Division of Oncology, Washington University School of Medicine, St. Louis, MO
²Division of Oncology/Department of Medicine, Washington University School of Medicine, St Louis, MO
³Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁴Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
⁵Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Massimo Martino, M.D.^1*, Messina Giuseppe, M.D.^2*, Roberta Fedele, M.D.^3*, Giuseppe Irrera, M.D.^2*, Console Giuseppe, M.D.^2*, Giuseppe Alberto Gallo^2*, Iolanda Donatella Vincelli^4*, Francesca Ronco^4*, Massimo Gentile, MD^5* and Fortunato Morabito, MD^6,7*

¹Hematology and Stem Cell Transplant Unit, Onco-hematology Department, "Bianchi-Melacrino-Morelli" Hospital, Reggio Calabria, Italy
²Hematology and Stem Cell Transplant Unit, Azienda Ospedaliera BMM, Reggio Calabria, Italy
³Hematology and Stem Cell Transplant Unit, Azienda Ospedaliera BMM, Hospital, Reggio Calabria, Italy
⁴hematology, azienda ospedaliera bianchi-melacrino-morelli, reggio calabria, Italy
⁵U.O.C. di Ematologia, Azienda Ospedaliera di Cosenza, Cosenza, Italy
⁶Section of Hematology, A.O. L'Annunziata of Cosenza, Cosenza, Italy
⁷Biotechnology Research Unit, Aprigliano (Cosenza), Italy

Giovanni Marconi, MD^1*, Cristina Papayannidis, MD, PhD², Federico Mosna^3*, Michele Gottardi^3*, Giorgia Simonetti, PhD^1*, Simona Soverini⁴, Antonio Curti, MD, PhD^5*, Elisa Zuffa, PhD^1*, Maria Chiara Abbenante, MD^1*, Sarah Parisi, M.D.^5*, Stefania Paolini, MD^5*, Chiara Sartor^5*, Eugenia Franchini^1*, Emanuela Ottaviani^1*, Claudia Venturi, PhD^4*, Maria Chiara Fontana^6*, Antonella Padella^1*, Viviana Guadagnuolo, PhD^1*, Maria Teresa Bochicchio^5*, Anna Ferrari, PhD^1*, Nicoletta Testoni^1*, Carmen Baldazzi, PhD^1*, Marco Manfrini, PhD^2*, Debora Capelli, MD^7*, Piero Galieni^8*, Andrea Piccin, MD^9*, Giuseppe Visani, M.D.^10*, Francesco Rodeghiero¹¹, Cristina Tecchio^12*, Filippo Gherlinzoni, MD¹³, Michele Cavo^5* and Giovanni Martinelli, MD, PhD²

¹University of Bologna, Bologna, Italy
²Bologna University School of Medicine, Bologna, Italy
³Department of Hematology, General Hospital, Treviso, Italy
⁴Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
⁵Institute of Hematology, Bologna, Italy
⁶"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁷Haematology Clinic, Ospedali Riuniti di Ancona, Ancona, Italy
⁸Hematology and Cellular Therapy, Ospedale Mazzoni, Ascoli Piceno, Italy
⁹Department of Haematology and BMT Unit. Bolzano Regional Hospital, Bolzano, Italy
¹⁰Hematology, AORMN Hospital, Pesaro, Italy
¹¹Department of Cell Therapy and Hematology, S. Bortolo Hospital, Vicenza, Italy
¹²Department of Hematology, University of Verona, Verona, Italy
¹³Unita Operativa Ematologia, Ospedale Ca' Foncello, Treviso, Italy

Jaakko Valtola, MD^1*, Ville Varmavuo, MD, PhD^1*, Antti Ropponen, BS^2*, Tuomas Selander, MSc^3*, Hanne Kuitunen, MD^4*, Leena Keskinen, MD^5*, Kaija Vasala, MD, PhD^6*, Tapio Nousiainen, MD, PhD^1*, Pentti Mäntymaa, MD, PhD^7*, Jukka Pelkonen, MD, PhD^2,7* and Esa Jantunen, MD, PhD^1*

¹Department of Medicine, Kuopio University Hospital, Kuopio, Finland
²Department of Clinical Microbiology, University of Eastern Finland, Kuopio, Finland
³Science Services Center, Kuopio University Hospital, Kuopio, Finland
⁴Department of Medicine, Oulu University Hospital, Oulu, Finland
⁵Department of Oncology, Tampere University Hospital, Tampere, Finland
⁶Department of Oncology, Central Hospital of Central Finland, Jyväskylä, Finland
⁷Laboratory of Eastern Finland, Kuopio, Finland

Ashley E Rosko, MD¹, Craig C Hofmeister, MD, MPH¹, Yvonne A Efebera, MD², Don M Benson, MD, PhD¹, Douglas W Sborov, MD, MS³, Samantha Jaglowski, MD, MPH^4*, Steve Devine, MD^2*, Tanya M Wildes, MD, MSCI⁵, James Gillahan^6*, Desiree Jones^7*, Ying Huang, MA, MS^7* and Christin E Burd, Ph.D.^8*

¹Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
²The Ohio State University, Columbus, OH
³Department of Internal Medicine, Hematology/Oncology fellowship, The Ohio State University, Columbus, OH
⁴Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁵Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
⁶The Ohio State University, Columbus
⁷Division of Hematology, The Ohio State University, Columbus, OH
⁸The Ohio State University, Department of Molecular Genetics, Columbus